CardioDx Inc – Company Profile & SWOT Analysis

CardioDx Inc – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

CardioDx Inc (CardioDx) is a molecular diagnostics company, which specializes in cardiovascular genomics. It develops clinically validated tests to help clinicians personalize care for patients with cardiovascular diseases such as coronary artery disease, cardiac arrhythmias and heart failure. The company’s flagship product, Corus CAD test, is used for assessing if the patients suffering with chest pain or other symptoms are having obstructive CAD (Coronary Artery Disease). CORUS CAD test has been clinically validated in two multicenter studies – COMPASS and PREDICT – in the US. The company also conducted DISCERN (diagnostic investigation of sudden cardiac event risk) multi-center clinical study along with its leading cardiologists in the area of cardiac arrhythmias. CardioDx is headquartered in Palo Alto, California, the US.

Scope

• Detailed information on CardioDx Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting CardioDx Inc in the form of a SWOT analysis

• An in-depth view of the business model of CardioDx Inc including a breakdown and examination of key business segments

• News about CardioDx Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess CardioDx Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on CardioDx Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Genomic Health Inc

Cardiocom LLC

Koninklijke Philips NV

Laboratory Corp of America Holdings

Phalanx Biotech Group

Table of Contents